Walnut Creek, CA, United States of America

Henry F VanBrocklin

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henry F VanBrocklin. Retrieved from https://idiyas.com/inventor/henry-f-vanbrocklin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Henry F VanBrocklin: Innovator in Clinical Imaging Applications

Introduction

Henry F VanBrocklin is a notable inventor based in Walnut Creek, California. He has made significant contributions to the field of clinical imaging through his innovative work on rotenone analogs. His research focuses on the preparation and application of these compounds, which have important implications for medical diagnostics.

Latest Patents

VanBrocklin holds a patent for "Rotenone analogs: method of preparation and use." This invention provides methods for creating and utilizing rotenone analogs that are labeled with single photon and positron emitting isotopes. These analogs are particularly useful in clinical imaging applications, serving as tracers to measure cardiac blood flow and detect regions of ischemia.

Career Highlights

Henry F VanBrocklin is affiliated with the University of California, where he continues to advance research in the field of clinical imaging. His work has garnered attention for its potential to improve diagnostic techniques and patient outcomes.

Collaborations

Some of his notable coworkers include James Patrick O'Neil and Andrew R Gibbs, who have collaborated with him on various research projects.

Conclusion

Henry F VanBrocklin's contributions to the field of clinical imaging through his patented inventions highlight the importance of innovation in medical diagnostics. His work continues to pave the way for advancements that can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…